{
  "url": "https://openlegislation.uk/human-medicines-regulations-2012/schedule-4/paragraph-14",
  "json_url": "https://openlegislation.uk/human-medicines-regulations-2012/schedule-4/paragraph-14.json",
  "legislation": "uksi/2012/1916",
  "legislation_title": "The Human Medicines Regulations 2012",
  "legislation_url": "https://openlegislation.uk/human-medicines-regulations-2012",
  "path": "schedule/4/paragraph/14",
  "kind": "paragraph",
  "number": "14",
  "heading": null,
  "text": "The licence holder must take all reasonable precautions and exercise all due diligence to ensure that any information provided to the licensing authority is not false or misleading in any material particular if—\n(a) it relates to a medicinal product which the licence holder manufactures or assembles; or\n(b) it relates to any starting materials or intermediate products held by the licence holder which are for use in the manufacture of medicinal products.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2012/1916/schedule/4/paragraph/14",
    "retrieved_at": "2026-10-29T01:24:34.993203+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}